Investing Ideas
/
New Zealand Pharmaceuticals & Biotech Potentially Undervalued Companies

New Zealand Pharmaceuticals & Biotech Potentially Undervalued Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies with a Value score of at least 3, ordered by Value score

1 companies

BLIS Technologies

Market Cap: NZ$19.2m

Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity.

BLT

NZ$0.015

7.1%

-16.7%